期刊文献+

肾结石合并非特异感染的细菌学研究 被引量:3

下载PDF
导出
摘要 目的探讨肾结石合并非特异感染的细菌学特点,了解常见致病菌的种类、菌谱特点、发生频率、对抗生素的耐药性和敏感性。方法通过经皮肾穿刺或输尿管导管留取318例肾结石合并非特异感染患者肾盂尿液,统计尿细菌培养和药物敏感试验结果。结果检出细菌334株,其中革兰阳性菌32.33%(108/334),革兰阴性菌60.17%(201/334)。药敏试验结果不同于菌种抗菌谱,有明显差异。结论肾结石合并非特异感染菌种分布广,不同菌种对抗生素的敏感性差异明显,提示临床应根据不同菌种和药敏试验结果合理选择抗生素。
出处 《南方医科大学学报》 CAS CSCD 北大核心 2010年第3期617-619,共3页 Journal of Southern Medical University
基金 广东省自然科学基金(05015806) 广东省医学科研基金(A2009292)
  • 相关文献

参考文献14

  • 1Holmgren K. Urinary calculi and urinary tract infection. A clinical and microbiological study [J]. Scand J Urol Nephrol Suppl, 1986, 98: 1-71.
  • 2Hugosson J, Grenabo L, Hedelin H, et al. Chronic urinary tract infection and renal stones [J]. Scand J Urol Nephrol, 1989, 23 (1): 61-6.
  • 3姚剑,顾金华.上尿路结石的细菌学研究及其临床意义[J].中华泌尿外科杂志,2005,26(8):542-544. 被引量:66
  • 4National Committee for Clinical Laboratory Standards (NCCLS). Perfermance stands for antimicrobial susceptinility testing [S ]. Ninth Informational Supplement. 2001: 122.
  • 5Kumazawa J, Matsumoto T. Complicated UTIs [M]//Bengan T. lnfectiology. Basel: Karger, 1997: 9-26.
  • 6Naber KG. Experience with the new guidelines on evalution of new anti-infective drugs for the treatment of urinary tract infections [J]. Int J Antimicrob Agents, 1999, 11: 189-96.
  • 7陈楠,陈晓农.复杂性尿路感染的诊断与治疗[J].中华全科医师杂志,2005,4(9):522-523. 被引量:27
  • 8Hugosson J, Grenabo L, Hedelin H. Bacteriology of upper urinary tract stones[J].J Urol, 1990, 143(5): 965-8.
  • 9Yoshida O, Kiriyama T, Okada K, et al. A bacteriological study on urinary calculi associated with infections [ J ]. Hinyokika Kiyo, 1984, 30(2): 191-8.
  • 10Gault MH, Longerich LL, Crane G, et al. Bacteriology of urinary tract stones[J].J Urol, 1995, 153(4): 1164-70.

二级参考文献20

  • 1National Committee for Clinical Laboratory Standard, 2002. Performance Standards for Antimicrobial Susceptibility Testing. NCCLS, Wayne, Pa.
  • 2Rhomberg PR, Jones RN , MYSTIC Study Group. Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials:report from the MYSTIC Program (2002) in North America. Diagn Microbiol Infect Dis, 2003,47:365-372.
  • 3Pfaller MA, Jones RN , MYSTIC Study Group. Antimicrobial susceptibility of inducible Amp C β-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000. Int J Antimicrob Agents, 2002,19:383-388.
  • 4Sader HS, Biedenbach DJ ,Jones RN. Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis, 2003,47:361-364.
  • 5Sader HS, Gales AC, Pfaller MA, et al. Pathogen frequency and resistance patterns in Brazilian hospitals:summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis, 2001,5:200-214.
  • 6章咏裳.尿石成分、分析方法与应用[A].见:吴阶平主编.泌尿外科[C].济南:山东科学技术出版社出版社,1993.550-622.
  • 7Costerton J W, Stewart P S, Greenberg EP, et al. Bacterial biofilms : a common couse of perisistent infection. Science, 1999, 284: 1318-1322.
  • 8Wells WG, Woods GL, Jiang Q,et al.Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.J Antimicrob Chemoth,2004,53 Suppl 2:ii67-ii74.
  • 9Nicolle LE.Urinary tract pathogens in complicated infection and in elderly individuals.J Infect Dis,2001,183 Suppl 1:S5-S8.
  • 10Rubin RH, Shapiro ED, Andriole VT et al.Evaluation of new anti-infective drugs for the treatment of urinary tract infection.Clin Infect Dis, 1992,15 Suppl:S216-S227.

共引文献827

同被引文献17

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部